. Some authors report changes consistent with
experiment, the animals were allowed to go to term and deliver spontaneously. Delivery occurred from 2-12 days after the experiment (mean 6 days). Blood coagulation factor activities I, 11, V, VI1, VIII, IX, X, XI, XII, antithrombin 111, fibrin monomer, and fibrin degradation products were measured after delivery in the hypoxemic and control animals. Except for factor XII, values obtained from ten previously catheterized control fetal lambs after spontaneous delivery did not differ from the current control animals after delivery.
Values on postdelivery samples for the two control groups were therefore pooled for analysis. Factors VIII, and IX were found to show increased activity during the 2 wk after delivery in hypoxemic animals when compared with controls. In contrast, the values for factors 11, V, VII, X and fibrinogen showed lower activity in hypoxemic as compared to control animals during the early neonatal period. The study demonstrates that though there are no severe acute effects on blood coagulation during severe hypoxemia in the near-term fetus except perhaps transient low-grade disseminated intravascular coagulation, the episode of hypoxemia appears to alter the future development of blood coagulation factor activities during the early neonatal period.
Speculation
Hypoxemia in the near-term fetus delays the normal development of prothrombin, factors V, VII, X, and fibrinogen during the early neonatal period and accelerates the development of factors VIII and IX. The differences in factor responses may help explain the variable results reported in human infants. The results also suggest that both thrombotic and hemorrhagic tendencies might be a consequence of prenatal hypoxemia.
Hypoxemia in the newborn infant following delivery has been associated with various abnormalities of blood coagulation (1, 2, intravascular coagulation (5) wherea's others suggest changes related to decreased synthesis of clotting factors by the liver (2, 16) . When hypoxemia occurs before delivery, still other authors suggest an acceleration of the maturation of blood coagulation factor activities (1, 27) . Previous studies in our laboratory demonstrated that hypoxemia when induced early in the third trimester of pregnancy in the chronically catheterized fetal lamb did not result in major changes in blood coagulation factor activities. The current study examines the effects of an identical episode of hypoxemia on near-term chronically catheterized fetal lambs. As in the previous study of early gestation lambs, the abnormalities usually associated with hypoxemia including acidosis, hypotension and hypercarbia were minimal, allowing examination of the effects of a relatively pure state of hypoxemia.
MATERIALS AND METHODS
Pregnant mixed Dorset-Suffolk ewes were obtained from existing sources and were housed throughout the study at the University of Iowa Animal Quarters.
The gestational ages of the fetuses were known based upon induced ovulation techniques (10) . Before surgery the animals were fasted for 48 h. Anesthesia of the ewe and surgery on the fetus were performed as described previously (14, 24) . During the acute studies, the ewes with their chronically catheterized fetuses were transferred into small carts restricting them to upright position. Six of the chronically catheterized fetuses were exposed to hypoxemia. Four of the chronically catheterized fetal lambs served as concurrent controls.
Blood samples were obtained from the fetuses via the chronic catheters before the onset of hypoxemia. After removing an initial 1 ml of blood to clear the line of saline, a sample of blood totaling 9 ml was obtained for the various measurements to be described. After the initial 9 ml collection of blood, hypoxemia was induced in the six fetal lambs by placing a bag over the ewe's head and having her breathe a mixture of 11.1% oxygen balanced with nitrogen. The oxygen-nitrogen gas mixture was precalibrated with an accuracy level of +0.11% by Airproducts Company of Pennsylvania. At 30 min into hypoxemia, a second 9-ml blood sample was obtained from both hypoxemic and control fetuses. Hypoxemia was concluded after a total of 60 min by removing the bag and having the ewe breathe room. air. Prolonging the hypoxemic episode beyond 60 min always resulted in acidosis and occasionally hypotension and death to the fetus. These events would preclude spontaneous delivery of live born animals and our ability to examine the effects of hypoxemia on coagulation factor activities postnatally. For this reason the 60-min hypoxemic episode was used.
Third and fourth samples of blood totaling 9 ml each were obtained from the fetal lambs 30 min and 2% h from the completion of the hypoxemic stress. The animals were then returned to their permanent quarters. During the acute studies, 0.5 ml of blood was collected anaerobically in heparinized plastic syringes and measurements of pH, Pcoz, and Po2 were immediately determined with the appropriate pH, PCOZ, and Po2 electrodes at 39°C using a radiometer pH amp 72 NK2 acid base analyzer (Radi-ometer Company, Denmark). Protein content of fetal serum was determined on 0.5 ml of clotted blood using a refractometer (Medical Instruments Company, Baltimore, MD). Hemoglobin, hematocrit, and white blood cell counts were measured using a Coulter Model S on a 0.5 ml aliquot of blood that was anticoagulated with EDTA. Platelet counts were also obtained on this aliquot using phase microscopy. Epinephrine and norepinephrine were determined on a 2 ml aliquot collected in 40 p1 of anticoagulant containing 90 mg/ml EDTA, 60 mg/ml glutathione. A radioenzymatic assay (CAT-A-KIT, Upjohn Company, Kalamazoo, MI) as previously described by Passon and Peuler (21) was used for the epinephrine and norephrine determinations.
Coagulation factor activities were measured on plasma from 2.7 ml aliquots of blood anticoagulated with 0.3 ml of 0.05 M sodium citrate, pH 5.0. Standard techniques for measuring the prothrombin times (28) and partial thromboplastin times (23) were used. Specific factor activities 11, V, VII, VIII, IX, X, XI, and XI1 were measured using one-stage assays measuring the ability of the test plasma to correct plasma known to be deficient in the factor to be tested (20) . Human deficient plasmas were used and an adult sheep standard pool consisting of plasma from ten nonpregnant ewes was used for calibration. Fibrinogen concentration was measured as clottable protein (6) . Von Willebrand factor activity was measured using washed formalin fixed frozen platelets according to the method of Brinkhous and Read (3). Antithrombi I11 was measured in plasma using the synthetic substrate M tosyl-gly-proarg-p-nitroanilide as described by Leff, et al. (15) . All activities are quoted as % of the reference standard pool of sheep plasma obtained from ten nonpregnant ewes. Plasmin digestion products of fibrinogen/fibrin were measured in serum from a 0.5 ml aliquot of blood allowed to clot in 5 p1 of a solution of 0.05 M EACA, 0.125 M CaCl*, 10 U/ml thrombin. The method of Merskey and co-workers (17) using rabbit anti-sheep fibrinogen antibody and sheep fibrinogen coated red blood cells was used. Fibrin monomer was measured according to the method of Kisker et al. (12) on plasma from 2.7-ml aliquots of blood collected in 0.3 ml of anticoagulant containing 2% EDTA, 10 mg/ml soybean trypsin inhibitor, 100 U/ml heparin pH 7.4. Sheep fibrinogen and antisheep fibrinogen antibody were used throughout.
Fetal arterial, venous, and amniotic pressures were recorded continuously during the experiments using Stratham P23Db pressure transducers (Stratham Instruments Division, Inc.) and a Beckman R611 recorder. Fetal heart rate was monitored with a cardiotachometer triggered from the fetal arterial pressure pulse.
After the completion of the acute experiments, the fetal lambs were allowed to progress to term and deliver spontaneously. All six hypoxemic animals were delivered spontaneously as were the four control animals. Samples of blood were obtained within the first 48 h after delivery in all animals and sequential samples were obtained during the first 14 days after birth. One control animal died within 72 h after delivery from parental abuse (the mother had apparently laid on the lamb and he suffocated). Postdelivery samples were available from ten previously studied chronically catheterized fetal lambs. The results obtained on samples from these animals before delivery were the subject of a previous report (14) . The values of coagulation factor activities on these previous controls after delivery were compared with the values obtained on the four concurrent control lambs and the six hypoxemic lambs.
Baseline values before the introduction of hypoxemia were compared in the hypoxemic and control groups using one-way analysis of variance. The changes that occurred during hypoxemia (30 min) and after hypoxemia (30 min and 2% h) were compared in the two groups using a repeated measure analysis of variance. A significant interaction with hypoxemia would be indicated by a difference in the response across time in the hypoxemic group as compared with the control group. If the interaction test is not significant, one can assume any changes occuring with time were parallel in the two groups. If the interaction test was not significant, analysis for parallel changes with time in the two groups was carried out. The Bonferroni method was used to adjust for multiple comparisons (19) .
Multiple linear regression was used to compare the patterns of changes in the groups during the 14 days after delivery. Because of the wide variations in values obtained within 24 h of birth, regression curves were generated on samples obtained 24 h after delivery and for the subsequent 14 days. There were no differences between the four concurrent and ten previous control animals during the 14 days following delivery except for factor XI1 which was 24% lower in the concurrent controls when compared with the previous control animals. Thus except for factor XII, where only concurrent control values are used, comparison of hypoxemic animals with pooled values from both control groups are presented. Preliminary analysis indicated that the patterns of development during the 14 days after delivery were described either by linear or quadric regressions. Both linear and quadric models were therefore used to test for differences in the patterns of change between the control and hypoxemic groups during the first 14 days after delivery.
RESULTS
Baseline values and values at 30, 90 and 210 rnin during and after hypoxemia are presented in Tables 1 and 2 . There were no significant differences between the control and hypoxemic animals at time zero except that the mean hemoglobin values in the hypoxemic group (10 f 0.4 g/dl) was significantly lower than the mean value in the control group (1 1.4 f 1.1 g/dl) . Values obtained on the animals during hypoxemia (30-min samples) and after hypoxemia (90 and 120 min) did reveal certain changes. Changes specific to the hypoxemic group included an initial increase in the hemoglobin concentration from 10 k 0.4 g/dl at time zero to 10.6 f 0.4 g/dl at 30 min. There was also an increase, though not statistically significant in the hematocrit from 30.6 f 1.2% to 32.4
from 23.9 f 1.6 mmHg at time zero to 13.8 f 1.4 m m~~ at 30 min during hypoxemia-~ significant increase in the epinephrine and norepinephrine concentrations in the hypoxemic animals was also apparent. Epinephrine increased from a mean of 22 f 9 pg/ml to 419 f 199 pg/ml at 30 min whereas norepinephrine increased from 431 + 98 pg/ml at time zero to 2408 f 868 pg/ml at 30 min. A significant increase in the heart rate was seen at 210 min in the hypoxemic animals increasing from 149 2 7 beats/min at time zero to 194 f 9 beats/min at 210 min. All of these changes were apparent only in the hypoxemic animals and were significantly different from both the baseline values of the hypoxemic animals and from the values obtained in controls. A significant decrease in the hemoglobin concentration was seen in both groups at 210 min. This decrease was no doubt a reflection of the 40 ml of blood withdrawn from the animals during the experimental period. Only one significant change in blood coagulation factors was seen. This change was a significant increase in the fibrin monomer concentration from 5.6 -+ 0.8 pg/ml at time zero to 12.6 + 2.0 pg/ml at 90 min suggesting low-grade intravascular coagulation. The increase in fibrin monomer concentration was minimal and not accompanied by a significant decrease in antithrombin I11 concentration nor a significant increase in the concentration of the plasmin digestion products of fibrin/fibrinogen (FDP). Though not reaching the level of statistical significance, factor VIII activity did increase from 53.8 f 9.9% at time zero to 68 f 16.6% at 210 min in the hypoxemic group. Factor IX also increased from 42 f 6% at time zero to 50.5 f 9.7% at 210 min in the hypoxemic group. After the experiments all animals were allowed to proceed to term and delivered spontaneously. The hypoxemic animals delivered at 145 +_ 1.6 days and the control 145 + 1.2 days. The experimental day was 139 rl: 0.9 days or approximately 6 days before delivery (range of 2-12 days).
Figures 1-9 represent the regression curves for the coagulation factor activities (fibrinogen, factors 11, V, VII, VIII, IX, X, XI, XII) in the control and hypoxemic animals during the first 14 days after delivery. The mean and S.D. of values obtained within the first 24 h after delivery in control animals are represented by the bar at time zero. The regression curves begin 24 h after delivery. The solid line and shaded area are the regression curve for control animals indicating the mean and 95% confidence limits. The solid line and open area between dashed lines represents the mean and 95% confidence limits for the experimental group.
Fibrin/fibrinogen degradation products were normal at delivery and throughout the postnatal period and therefore are not plotted. Fibrin monomer levels in control and hypoxemic animals did not differ at birth or during the first 14 days after delivery. Group differences were also not seen in the postnatal development of factors XI, XII, or antithrombin 111.
Significant differences were however apparent in the other clotting factor activities. Fibrinogen, prothrombin, factors VII, and X reached their peak activities approximately 8 days after delivery in control animals. The postnatal development of these factors in the animals who had been exposed to hypoxemia however was significantly delayed but reached control levels by day 14. Factor V was also significantly lower in hypoxemic animals but also increased during the postnatal period reaching control levels by day 14. In contrast, values for factors VIII were significantly higher in hypoxemic animals throughout the postnatal period and factor IX activity increased in hypoxemic animals during the 14-day period exceeding control levels by the end of the second wk. Because the day of delivery was the same in both groups and the differences were apparent only in the hypoxemic animals, the changes observed appear to be related to the hypoxemic episode induced approximately 6 days before delivery.
DISCUSSION
Previous studies in our laboratory in which we subjected early third trimester fetal lambs (107-110 days gestation) to severe hypoxemia for 1 h demonstrated that the lambs tolerated hypoxemia without clinically significant alterations in blood coagulation factor activities (13) . During an 18-day follow-up period in these early gestation animals there was no evidence that hypoxemia resulted in any alteration of development except that control animals did increase their levels of factor X by 10.3% during the 18-day follow-up; an increase not apparent in the hypoxemic group.
A number of authors have reported significant changes in the blood coagulation factor activities in asphyxiated infants including evidence of decreased synthesis of liver dependent coagulation factor activities (2, 7, 8, 16) , disseminated intravascular coagulation (4, 5) and even accelerated maturation of blood coagulation (9, 27) . The variability in the results reported by different authors may reflect variations in the timing and duration of the hypoxemic episode, variation in the maturity of the infants studied, differences in the degree of acidosis, hypercarbia, hypotension and hypother-mia that might accompany the hypoxemic stress as well as complex changes resulting from the hypoxemic episode. The chronically catheterized fetal lamb has provided us with a tool whereby it is possible to study the effects of hypoxemia at specific gestational ages unaccompanied by severe acidosis, hypotension, or hypothermia. The current study was undertaken to determine the effects of severe hypoxemia on the near-term fetal lamb (6 days before delivery). The results confirmed expected physiologic changes in the hypoxemic group, including a decrease in Poz from 23.9 mmHg to 13.8 mmHg, and a decrease in Pcoz from 42.6 mmHg to 37.2 mmHg. Hypoxemia also resulted in a significant release of catecholamines. Epinephrine increased from 22 pg/ml before hypoxemia to 419 pg/ml during hypoxemia whereas norepinephrine increased from 410 pg/ml before hypoxemia to 2408 pg/ml. The increases in catecholamines were reflected by increases in the mean arterial pressure from 48 mmHg to 56 mmHg. The changes in the white blood cell count, factor VIII activity, and risocetin cofactor activity were not significant, which confirms the decrease response to cat-echolamines~riginally reported by Spirer and colleagues (26) in preterm infants. Though still within physiologic range, there was a slight decrease in pH from 7.36 to 7.32 in the hypoxemic animals. Initially, there was a slight increase in the hemoglobin concentration in the hypoxemic group. An overall decrease in hemoglobin was however apparent in both hypoxemic and control groups at the end of the experimental period undoubtedly due to the phlebotomy approximating 40 cc.
Minimal changes in coagulation factor activities were apparent during the acute hypoxemic . . from 5.6 pg/ml at time zero to 12.6 pg/ml at 90 min (30 min after hypoxemia). This was a significant though minimal change both from baseline values and from control values and is suggestive of low-grade disseminated intravascular coagulation. There were however, no significant changes in antithrombin 111 nor was there the appearance of fibrin degradation products in the plasma to confirm disseminated intravascular coagulation. Overall the nearterm fetal lamb is relatively resistant to the acute effects of severe hypoxemia, though demonstrating more response to catecholamines (increased mean arterial pressure, increased heart rate) than the early third trimester fetuses.
In contrast to minimal acute changes, significant changes were seen in the first 14 days after delivery. The development of fibrinogen, factors 11, VII, and X were significantly delayed during the early neonatal period in the hypoxemic animals. The delays were significant ( P = 0.02 for fibrinogen, P = 0.01 for factor 11, P = 0.01 for factor VII, and P = 0.01 for factor X; see Figs. 1, 2, 4, 7). Peak levels of activity in the control animals were reached approximately 8 days after delivery whereas the hypoxemic group did not reach control levels until day 14. Factor V activity in hypoxemic animals was lower than in controls on day 1 and appeared to gradually rise during the early neonatal period whereas levels on control animals decreased during the 14 day period (Fig. 3) . The differences are significant ( P = 0.01). In contrast to fibrinogen, factors 11, V, VII, and X where development was delayed in hypoxemic animals, factor VIII activity was increased in the hypoxemic animals throughout the early neonatal period as compared to controls ( P = 0.01; Fig. 5 ). Factor IX activity also increased in hypoxemic animals throughout the 14 days after delivery exceeding control levels by the end of the second wk (P = 0.01; Fig. 6 ). The increased activities of factors VIII and IX suggest that the hypoxemic episode in some way accelerated the maturation of these factors. The episode of hypoxemia in the near-term fetal lamb is complex and appears to result in impairment of development of some clotting factor activities (fibrinogen, factors 11, V, VII, and X) or whereas it accelerates the development of others (factors VIII and IX).
As reported by Dam (7) human infants who suffered intrauterine asphyxia had exceptionally low prothrombin activities. The studies by Hathaway and Henderson (8) in newborn puppies surviving prolonged periods (18-24 hs) of systemic hypoxia demonstrated deficiences of both vitamin K-dependent factors (11, VII, and X) and nonvitamin K-dependent factor, factor V. Vitamin K, if administered to the bitch, protected her newborn puppies against the effects of hypoxemia in Hathaway's studies. In our studies, the fetus was exposed to 1 h of severe hypoxemia an average of 6 days before delivery. We also observed an impairment in the development of some of the liver dependent factors including fibrinogen, factors 11, V, VII, and X during the first 14 days after delivery. We did not administer vitamin K to the mothers of any of these animals so we cannot comment on the protective effects that vitamin K may have on the fetus exposed to hypoxemia.
In contrast to the impaired development of fibrinogen, factors 11, V, VII, and X, both factors VIII and IX activities were increased in the hypoxemic group during the early neonatal period. Hathaway and Henderson (8) did not find any significant effects of hypoxemia on the activity of factor VIII in the newborn puppies in which it was measured and factor IX was not measured.
Hathaway and co-workers (9) in another study of newborn human infants of high risk pregnant women, however, did find increased factor VIII activity in the cord blood of 13 infants with fetal distress (9) . Similar to our findings in fetal lambs, Perlman and Dvilansky (22) observed increased factor VIII activity, low factor V activity, and fibrinogen in human newborns with gross placental infarction, a condition associated with fetal hypoxemia. Thomas (27) reporting on coagulation in low birth weight infants found better than normal coagulation in infants stressed as a result of maternal pre-eclampsia, toxemia, placental insufficency or antipartum hemorrhage. The values of specific factors were not presented and only fibrinogen concentration and a thrombotest was done on these infants.
Our studies suggest that fetal hypoxemia in the near-term fetus results in only minimal changes of coagulation factors during and immediately after the hypoxemic episode. Significant changes are, however, observed in the first 14 days after birth. These changes include an impairment in the development of fibrinogen, prothrombin, factors V, VII, and X and an enhancement of the activities of factors VIII and IX. There was no apparent effect on factors XI and XI1 and there was no suggestion of persistent disseminated intravascular coagulation.
The mechanisms for the differences observed during the early neonatal period in lambs exposed to hypoxemia near-term might be related to changes in protein syntheses and degradation; alterations in the specific activities of the proteins and/or variations in the levels of possible inhibitors of the activities of the proteins. It is unlikely that the differences are related to vitamin K because factor IX, a vitamin K-dependent factor, is increased whereas Fibrinogen and factor V show impaired development. Neither are vitamin K dependent factors. Though the mechanisms are unknown, the changes in the development of coagulation factor activities subsequent to fetal hypoxemia near-term could contribute to either neonatal thrombotic or hemorrhagic complications.
